TY - JOUR
T1 - Kynurenine pathway metabolic balance influences microglia activity
T2 - Targeting kynurenine monooxygenase to dampen neuroinflammation
AU - Garrison, Allison M.
AU - Parrott, Jennifer M.
AU - Tuñon, Arnulfo
AU - Delgado, Jennifer
AU - Redus, Laney
AU - O'Connor, Jason C.
N1 - Funding Information:
This research was supported by National Institute of Mental Health grant R01-MH090127 , VA Merit Award I01BX003195-01, NIH National Centers for Advancing Translational Sciences grant UL1 TR001120 and Texas Higher Education Coordinating Board NHARP 003659-0010-2012 (JCO), NIH Institutional training grant T32 NS 082145 (AMG), and the NIH National Research Service Award grant 1F31 MH102070-01A1 (JMP). We would like to thank Susan T. Weintraub, PhD and Xiaoli Gao, PhD at the University of Texas Health Science Center at San Antonio Mass Spectrometry Core Facilities for their assistance with LC/MS method design, sample preparation, sample analysis, and data collection. Mass spectrometry analyses were conducted on instrumentation obtained with funding from the National Institutes of Health ( 1S10OD016417-01 to STW). The content is the sole the responsibility of the authors and does not necessarily represent the views of the National Institute of Mental Health or the National Institutes of Health.
Publisher Copyright:
© 2018
PY - 2018/8
Y1 - 2018/8
N2 - Chronic stress or inflammation increases tryptophan metabolism along the kynurenine pathway (KP), and the generation of neuroactive kynurenine metabolites contributes to subsequent depressive-like behaviors. Microglia regulate KP balance by preferentially producing oxidative metabolites, including quinolinic acid. Research has focused on the interplay between cytokines and HPA axis-derived corticosteroids in regulating microglial activity and effects of KP metabolites directly on neurons; however, the potential role that KP metabolites have directly on microglial activity is unknown. Here, murine microglia were stimulated with lipopolysaccharide(LPS). After 6 h, mRNA expression of interleukin(IL)-1β IL-6, tumor necrosis factor(TNF)-α and inducible nitric oxide synthase(iNOS) was dose-dependently increased along with the rate-limiting enzymes for oxidative KP metabolism, indoleamine-2,3-dioxygenase(IDO)-1 and kynurenine 3-monooxygenase(KMO). By 24 h post-LPS, kynurenine and quinolinic acid in the media was elevated. Inhibiting KMO with Ro 61-8048 during LPS challenge attenuated extracellular nitrite accumulation and expression of KMO and TNF-α in response to LPS. Similarly, primary microglia isolated from KMO −/− mice exhibited a significantly reduced pro-inflammatory response to LPS compared to WT controls. To determine whether the substrate (kynurenine) or end product (quinolinic acid) of KMO-dependent metabolism modulates the LPS response, microglia were treated with increasing concentrations of L-kynurenine or quinolinic acid in combination with LPS or saline. Interestingly, quinolinic acid did not impact the microglial LPS response. However, L-kynurenine had dose-dependent inhibitory effect on the LPS response. These data are the first to show an anti-inflammatory effect of KMO inhibition on microglia during immune challenge and suggest that KP metabolic balance may play a direct role in regulating microglia activity.
AB - Chronic stress or inflammation increases tryptophan metabolism along the kynurenine pathway (KP), and the generation of neuroactive kynurenine metabolites contributes to subsequent depressive-like behaviors. Microglia regulate KP balance by preferentially producing oxidative metabolites, including quinolinic acid. Research has focused on the interplay between cytokines and HPA axis-derived corticosteroids in regulating microglial activity and effects of KP metabolites directly on neurons; however, the potential role that KP metabolites have directly on microglial activity is unknown. Here, murine microglia were stimulated with lipopolysaccharide(LPS). After 6 h, mRNA expression of interleukin(IL)-1β IL-6, tumor necrosis factor(TNF)-α and inducible nitric oxide synthase(iNOS) was dose-dependently increased along with the rate-limiting enzymes for oxidative KP metabolism, indoleamine-2,3-dioxygenase(IDO)-1 and kynurenine 3-monooxygenase(KMO). By 24 h post-LPS, kynurenine and quinolinic acid in the media was elevated. Inhibiting KMO with Ro 61-8048 during LPS challenge attenuated extracellular nitrite accumulation and expression of KMO and TNF-α in response to LPS. Similarly, primary microglia isolated from KMO −/− mice exhibited a significantly reduced pro-inflammatory response to LPS compared to WT controls. To determine whether the substrate (kynurenine) or end product (quinolinic acid) of KMO-dependent metabolism modulates the LPS response, microglia were treated with increasing concentrations of L-kynurenine or quinolinic acid in combination with LPS or saline. Interestingly, quinolinic acid did not impact the microglial LPS response. However, L-kynurenine had dose-dependent inhibitory effect on the LPS response. These data are the first to show an anti-inflammatory effect of KMO inhibition on microglia during immune challenge and suggest that KP metabolic balance may play a direct role in regulating microglia activity.
KW - Cytokines
KW - Inflammation
KW - Kynurenine metabolism
KW - Microglia
UR - http://www.scopus.com/inward/record.url?scp=85046786158&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046786158&partnerID=8YFLogxK
U2 - 10.1016/j.psyneuen.2018.04.019
DO - 10.1016/j.psyneuen.2018.04.019
M3 - Article
C2 - 29734055
AN - SCOPUS:85046786158
SN - 0306-4530
VL - 94
SP - 1
EP - 10
JO - Psychoneuroendocrinology
JF - Psychoneuroendocrinology
ER -